NCT07067710 The Use of Combined Motor Imagery and Action Observation to Evaluate the Influence on Functional Parameters Such as Strength, Range of Motion, Pain or Fear of Movement Among Others, in Females Breast Cancer Survivors.
| NCT ID | NCT07067710 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Fundacion Miguel Servet |
| Condition | Breast Cancer Survivor |
| Study Type | INTERVENTIONAL |
| Enrollment | 108 participants |
| Start Date | 2025-02-25 |
| Primary Completion | 2025-04-28 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 108 participants in total. It began in 2025-02-25 with a primary completion date of 2025-04-28.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this study is to evaluate the effectivity of the combined motor imagery and action observation therapies to improve functional parameters such as strenght, range of motion, pain or fear of movements among others in relation to upper limb in breast cancer survivors. The main question it aims to answer is: Will a combined therapy of motor imagery and action observation improve the strenght, rang of motion, pain, limb diameter and fear of movement of the upper limb in breast cancer survivor females? The participants will be part of the IM-OA23 proyect that consist on seeing some diferent videos about upper limb mobility and then they'll have to imagine the movements and to performed themselves. Researches will compare two groups (control group and intervention group) to evaluate the diferences between them.
Eligibility Criteria
Inclusion Criteria: * Female, over 18 years, have suffered breast cancer, have ended active treatments (chemotherapy, radiotherapy, surgery), have pain or functional limitation or lymphedema at upper limb afected. Exclusion Criteria: * males, people with active treatments ongoning, other types of cancer, recurrence or metastasis of cancer
Contact & Investigator
Paula Escalada-Hernández, PhD
STUDY DIRECTOR
Public University of Navarra
Frequently Asked Questions
Who can join the NCT07067710 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Breast Cancer Survivor. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07067710 currently recruiting?
Yes, NCT07067710 is actively recruiting participants. Contact the research team at pilararnal3b@gmail.com for enrollment information.
Where is the NCT07067710 trial being conducted?
This trial is being conducted at Pamplona, Spain, Pamplona, Spain, Pamplona, Spain.
Who is sponsoring the NCT07067710 clinical trial?
NCT07067710 is sponsored by Fundacion Miguel Servet. The principal investigator is Paula Escalada-Hernández, PhD at Public University of Navarra. The trial plans to enroll 108 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.